Analysis of liquid biopsies from metastatic colorectal carcinoma (mCRC) patients (pts) enrolled in the ERMES clinical trial.

Nicola Normanno,Carlo Barone,Evaristo Maiello,Francesco Di Costanzo,Antonio Cassata,Emiliano Tamburini,G. Tonini,Roberto Bordonaro,Gerardo Rosati,Alberto Zaniboni,Sara Lonardi,Daris Ferrari,Giovanni Luca Frassineti,Stefano Tamberi,Salvatore Pisconti,Francesca Di Fabio,Laura Forgione,Anna Maria Rachiglio,Raffaella Pasquale,Carmine Pinto

Analysis of liquid biopsies from metastatic colorectal carcinoma (mCRC) patients (pts) enrolled in the ERMES clinical trial.

2018

e15507Background: Liquid biopsy is an alternative to tissue biopsy for biomarker testing. In addition, it can be used to monitor the response to therapy and the molecular evolution of the disease. ...

Keywords:

Clinical trial
Pathology
Cancer research
Colorectal cancer
ERMES
Medicine
response to therapy
tissue biopsy
Oncology
Liquid biopsy
Internal medicine
Biomarker (medicine)
Disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations